admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Pα+: Dispatch from ‘Advancing Psychedelic Clinical Study Design’, Hosted by the...

PT486 – 5-MeO-DMT, Somatic Release, and Creating Context for Spirituality

Psychedelic Research Bulletin: January 2024

PT485 – Meeting People Where They Are: Why the Underground Will...

The Interdisciplinary Annotated Psychedelic Research Bibliography of 2023

Pα+ Psychedelic Bulletin #155: MAPS Invests in Numinus, Hopes to Offer...

Sacred Mycology Summit: A Three Day Online Educational Gathering

Magic Mushroom Industry Leaders: Top Cultivation Companies

The Psychedelic Drug Development Pipeline: Bullseye Chart Year-End 2023

PT484 – Seeing Through the Smoke: The Importance of Telling the...

1...303132...218 Page 31 of 218

EDITOR PICKS

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin